Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting ...

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...

U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.

The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a ...

FDA approves Lumipulse G, the first blood test that can help in the diagnosis of Alzheimer's disease. Read more here.

The FDA has cleared a new blood test that would significantly help in diagnosing patients with Alzheimer's disease. Unlike costly PET scans, this simple blood draw detects a key marker of Alzheimer’s.